AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma

Phase 1 Unknown 50 enrolled Zhejiang University Yake Biotechnology Ltd. · collab

NaSingle-groupOpen-labelTreatment

Summary

Clinical Study on the Safety and Effectiveness of Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma

Timeline

Start: 2023-03
Primary completion: 2025-03
Completion: 2025-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BCMA CAR-T cells	Cell therapy	—	—

AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma

Summary

Timeline

Drugs

Indications